Edition:
United States

Protalix Biotherapeutics Inc (PLX)

PLX on American Stock Exchange

0.65USD
25 Jul 2016
Change (% chg)

$0.01 (+1.50%)
Prev Close
$0.64
Open
$0.64
Day's High
$0.66
Day's Low
$0.64
Volume
56,804
Avg. Vol
76,655
52-wk High
$1.78
52-wk Low
$0.61

PLX

Chart for PLX

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other... (more)

Overall

Beta: 0.81
Market Cap(Mil.): ₪245.54
Shares Outstanding(Mil.): 99.81
Dividend: --
Yield (%): --

Financials

  PLX Industry Sector
P/E (TTM): -- 39.80 37.05
EPS (TTM): -1.16 -- --
ROI: -47.43 -5.86 14.35
ROE: -- -4.70 15.56

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.